Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell...
Read more
March 2023 EIPM Director’s Memo Dear Friends, We just published a new animated video about the EIPM, which I hope you enjoy and will share with friends and colleagues! You can find it on our website, Twitter feed, Facebook page, and ...
Read more
Endothelial cells—the cells that line blood vessels—grown alongside leukemia cells become corrupted and rescue the cancer cells from many chemotherapy drugs, a study by Weill Cornell Medicine investigators found. A growing body of evidence...
Read more
Dear Members of the Englander Institute, I hope you were able to take some time off this summer and relax with friends and family members, and hopefully recharge for a productive autumn. As you’ll see below, members of the EIPM had a very...
Read more